Skip to content
Bandaram Pharma Packtech logo

Bandaram Pharma Packtech

524602 BSE
₹19.03

Close ·

P/E
33.98
View as Markdown
MCP
Close 4 Nov 2026 ₹19.03 −7.34 −27.8% 1Y
Start ₹26.37

Key Fundamentals

MicrocapHealthcare ServicesHealthcare

Price-based figures at the close · EPS basis: Consolidated · TTM

ROCE
4.44%
Debt to Equity
0.89
EPS (TTM)
₹0.56
Book Value
₹14.88
Market Cap
—
P/E (TTM)
33.98
P/B
1.28
ROE
1.42%
Dividend Yield
0.53%
EBITDA
₹2.90 Cr
52W High
₹49.70
52W Low
₹17.25

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

39 Weak

Data confidence 98/100

Category scores

Quality
27
Poor
Returns, margins, earnings quality 22% weight
Valuation
40
Weak
Cheap vs sector & own history 24% weight
Growth
99
Strong
Sales & profit trajectory 9% weight
Financial Health
24
Poor
Solvency, leverage, coverage 9% weight
Momentum
15
Poor
Trend strength, vol-adjusted 12% weight
Ownership
50
Average
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

1
  • Company is expected to give good quarter

Weaknesses

4
  • Company has a low return on equity of 5.57% over last 3 years.
  • Company might be capitalizing the interest cost
  • Company has high debtors of 182 days.
  • Promoter holding has decreased over last 3 years: -12.3%

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallBearish766
OscillatorsBullish063
Moving AveragesStrong Bearish703

Key readings

RSI (14)
48.72
Neutral
MACD (12,26,9)
−0.19
Bullish
SMA (50)
19.61
Bearish
SMA (200)
24.72
Bearish

As of

Growth Rate

From the financial statements below. 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
3Y+49.77%
1Y+70.24%
TTM+133.74%

Net profit

Net profit growth by window
3Y+2.50%
1Y−71.72%
TTM+43.90%

Operating cash flow

Operating cash flow growth by window
3YOutflow widened by ₹3.82 Cr
1YOutflow narrowed by ₹0.01 Cr
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
3Y−1.52 pp
1Y−3.04 pp
TTM−3.81 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2022₹0.00 Cr
Mar 2023₹18.73 Cr
Mar 2024₹34.08 Cr
Mar 2025₹36.96 Cr
Mar 2026₹62.92 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2022−₹0.01 Cr
Mar 2023₹0.26 Cr
Mar 2024₹0.95 Cr
Mar 2025₹0.99 Cr
Mar 2026₹0.28 Cr

Quarterly Results

₹ Cr
524602 quarterly results, ₹ crore
Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
5.87
7.36
7.36
13.43
11.37
7.11
10
8.49
8.1
13.72
14.84
26.26
23.95
Expenses
5.34
6.89
6.89
12.7
10.83
6.02
9.34
7.95
7.47
13.27
13.84
25.44
22.4
Operating Profit
0.53
0.47
0.47
0.73
0.54
1.09
0.66
0.54
0.63
0.45
1
0.82
1.55
OPM %
9.03%
6.39%
6.39%
5.44%
4.75%
15.33%
6.6%
6.36%
7.78%
3.28%
6.74%
3.12%
6.47%
Other Income
0
0
0
0.03
0
0
0
0.09
0
0.01
0
0.01
0
Interest
0.28
0.17
0.17
0.32
0.21
0.26
0.24
−0.1
0.46
0.25
0.33
0.46
0.42
Depreciation
0.18
0.18
0.18
0.19
0.15
0.15
0.15
0.53
0.13
0.14
0.14
0.25
0.2
PBT
0.07
0.12
0.12
0.25
0.18
0.68
0.27
0.2
0.04
0.07
0.53
0.12
0.93
Tax %
0%
0%
0%
24%
0%
0%
103.7%
25%
25%
28.57%
33.96%
25%
25.81%
Net Profit
0.07
0.12
0.12
0.19
0.18
0.67
−0.02
0.15
0.02
0.06
0.35
0.09
0.68
EPS (₹)
0.06
0.1
0.1
0.16
0.15
0.56
−0.01
0.12
0.02
0.02
0.11
0.05
0.38

Profit & Loss

₹ Cr
524602 profit and loss, annual, ₹ crore
Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
0
18.73
34.08
36.96
62.92
78.77
Expenses
0.01
17.58
31.26
34.13
60.01
74.95
Operating Profit
−0.01
1.15
2.82
2.83
2.91
3.82
OPM %
—
6.14%
8.27%
7.66%
4.62%
4.85%
Other Income
0
0.19
0.03
0.09
0.02
0.02
Interest
0
0.43
0.93
0.99
1.51
1.46
Depreciation
0
0.59
0.73
0.61
0.97
0.73
PBT
−0.01
0.32
1.19
1.32
0.45
1.65
Tax %
0%
21.88%
20.17%
24.24%
35.56%
—
Net Profit
−0.01
0.26
0.95
0.99
0.28
1.18
EPS (₹)
−0.01
0.12
0.79
0.82
0.16
0.56
Div. Payout %
0%
21.43%
12.63%
12.12%
0%
—

Balance Sheet

₹ Cr
524602 balance sheet, annual, ₹ crore
Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
7.06
3
12
12
17.97
Reserves
−0.06
0.08
0.28
0.65
8.81
Borrowings
0
14.2
12.2
17.15
23.95
Other Liabilities
0.48
2.9
7.58
9.12
25.13
Total Liabilities
7.48
20.18
32.06
38.92
75.86
Fixed Assets
2.87
5.03
4.48
3.95
15.22
CWIP
0
0
0
0
0
Investments
2.09
0
1.4
1.4
0
Other Assets
2.52
15.15
26.18
33.57
60.64
Total Assets
7.48
20.18
32.06
38.92
75.86

Cash Flow

₹ Cr
524602 cash flow, annual, ₹ crore
Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
—
−1.1
−4.13
−4.93
−4.92
Investing
—
−5.3
−1.58
−0.08
0
Financing
—
4.47
5.59
5.09
5.53
Net Cash Flow
—
−1.93
−0.11
0.08
0.6
Free Cash Flow
—
−3.89
−4.31
−5.01
−4.92
CFO/OP
—
−96
−139
−163
−169

Ratios

524602 financial ratios, annual
Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
—
129
156
185
182
Cash Conversion Cycle
—
129
156
185
182
Working Capital Days
—
147
148
165
127
ROCE %
—
5.69%
9.1%
7.67%
4.44%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Bandaram Pharma Packtech insights

58 extracted metrics across FY00–FY27.

Shareholding Pattern

As of Sep 2026

  • Promoters 62.66%
  • Public 36.16%
  • Others 1.17%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Documents

Frequently Asked Questions about Bandaram Pharma Packtech

What does Bandaram Pharma Packtech Ltd do?
Incorporated in 2022, Bandaram Pharma Packtech Ltd deals in procurement and supply of recycled paper
Where is Bandaram Pharma Packtech Ltd (BANDARAM) listed?
Bandaram Pharma Packtech Ltd trades under code 524602 on the BSE.
Which sector does Bandaram Pharma Packtech Ltd belong to?
Bandaram Pharma Packtech Ltd is classified under the Healthcare Services sector, in the Healthcare Service Provider industry.
What is the PE ratio of Bandaram Pharma Packtech Ltd?
Bandaram Pharma Packtech Ltd trades at a PE ratio of 33.98 as of 4 Nov 2026, on earnings per share of ₹0.56, against a book value of ₹14.88 per share.
What is the 52-week high and low of Bandaram Pharma Packtech Ltd?
Over the last 52 weeks Bandaram Pharma Packtech Ltd has traded between ₹17.25 and ₹49.7 as of 4 Nov 2026.
Does Bandaram Pharma Packtech Ltd pay dividends?
Bandaram Pharma Packtech Ltd has a dividend yield of 0.53%.
What is the Return on Equity (ROE) of Bandaram Pharma Packtech Ltd?
Bandaram Pharma Packtech Ltd reported a return on equity of 1.42%. Its debt-to-equity ratio is 0.89.

Company Information

Incorporated in 2022, Bandaram Pharma Packtech Ltd deals in procurement and supply of recycled paper

Website bandaram.com
CEO Mr. Bandaram Deepak Reddy
Employees 21
Listed 22 Dec 2022
Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/524602.md for Bandaram Pharma Packtech Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Hospital & Healthcare Services stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month